Caliway Biopharmaceuticals Co., Ltd. (TPE:6919)
Taiwan · Delayed Price · Currency is TWD 162.00
-3.00 (-1.82%)
Oct 28, 2025, 2:38 PM CST
TPE:6919 Market Cap
TPE:6919 has a market cap or net worth of 255.92 billion as of October 27, 2025. Its market cap has increased by 240.56% in one year.
Market Cap
255.92B
Enterprise Value
246.53B
Revenue
44.83M
Ranking
n/a
PE Ratio
n/a
Stock Price
162.00
Market Cap Chart
Since December 26, 2022, TPE:6919's market cap has increased from 7.96B to 255.92B, an increase of 3,115.69%. That is a compound annual growth rate of 239.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2025 | 255.92B | 171.20% |
| Dec 31, 2024 | 94.36B | 300.87% |
| Dec 29, 2023 | 23.54B | 212.69% |
| Dec 30, 2022 | 7.53B | -5.41% |
| Dec 26, 2022 | 7.96B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 186.03B |
| Bora Pharmaceuticals Co., LTD. | 77.82B |
| Lotus Pharmaceutical | 74.82B |
| Lumosa Therapeutics | 47.00B |
| Oneness Biotech | 30.13B |
| Polaris Group | 27.85B |
| Center Laboratories | 25.76B |
| Pegavision | 24.84B |